Director, Global Capital Project Delivery at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Bachelor’s degree in Engineering (Chemical/Mechanical preferred). PMP certification & EIT/PE License a plus
Minimum 10-15 years’ experience managing pharmaceutical capital projects (Manufacturing, Lab, Office, Pilot Plant, etc.) inclusive of planning, design, procurement, scheduling, execution, commissioning & qualification, technical transfer of technology and concepts (as applicable)

Responsibilities

Develop and manage a portfolio of capital projects with emphasis on R&ED Laboratories and Chemical Development Projects, as well as site utility and infrastructure upgrades in support of the business strategy
Ensure compliance with Bristol Myers Squibb Global Engineering Governance model, standards (including all applicable safety, regulatory, legal requirements) and finance requirements
Ensure appropriate internal and external resources are incorporated into capital project design and execution and provide financial oversight through management of scope and regular review of change requests, schedule, cost and cash flow projections, risk management, monthly project reporting, and financial audit preparation
Lead the scheduling, planning, control and effective coordination of all the parallel activities related to each project and maintain project schedule through minimal unanticipated schedule challenges
Collaborate with Global Engineering, Facilities, Procurement and site leadership to develop and analyze capital project cash flow forecasts, suggest risk adjustments as needed, and deliver cost-effective capital projects to end users
Mentor and lead network learning and best practice sharing to build an efficient, high-performing department
Achieve high customer satisfaction by delivering finished projects on time that are fully commissioned, qualified and ready for startup/occupancy, and meet all requirements of stakeholders

Skills

Project Management

Capital Projects

Project Controls

Construction Management

Budget Management

Schedule Management

Portfolio Management

Governance

Team Leadership

Resource Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free